Author Archives: mal054

K2-News Week 12

The University of Bergen should deliver on four social issues, namely: research, education, dissemination and innovation. Previously, K2´s leadership had a strong focus on the fact that the Institute’s research would benefit society and K2 is therefore an institute that has thus far maintained its reputation in the field of innovation. The institute contributes many innovative projects where cooperation with both the hospital and the business community is central, among other things within drug development, medical technology and nutrition. Many will probably think that running innovation takes time from research and teaching and should just be a secondary consideration at UiB. However, the development of research ideas with commercial potential can be an excellent way to expand both networking and funding potential for project financing. The development of products and processes can also contribute to new research ideas. In K2, news no. 4, Amra focused on the importance of planning the application processes towards external funding sources. This is also true for innovation and commercialization projects.

The University of Bergen has set up Bergen Teknologioverføring AS (BTO) to help handle the further development of research ideas with social or commercial potential. Very often, in the development of these ideas and projects, its critical to apply for funds, just as in research. BTO has gradually gained experience with applications towards the various different funding programs availible. First and foremost, it is very important to get started as soon as possible with the application. The fact that these projects often also have more external partners only reinforce the importance of starting early. Furthermore, it is extremely important not just to describe the research or technical aspects, but also the usefulness and the commercial aspect. Business developers at the TTOs know how to best describe this. In addition, they often seek advice and assistance from external advisors to review the applications and provide feedback. BTO also cooperates closely with our administration at K2 and with the research advisors in the application processes. Here are some of the most important programs where UiB collaborates with BTO to get project funding, but there are of course many others, depending on the subject area and themes. Start by checking out these and see if there are some opportunities for financing some of your great ideas:

BIOTEK 2021 Optimizers: Project ideas with a commercial potential in biology and biomedicine can receive funding at a relatively early phase for further development. It is UiB which is the applicant institution, but it is mandatory to have a TTO onboard (in UiBs case, BTO), to ensure that the project evolves in a commercial direction.

STUDENT: Students with a good idea can earn up to NOK 1 million to further develop their idea commercially. It is UiB, which is the sender of an application to the Research Council of Norway. The scheme is aimed at those who are (or almost) at the master’s level. BTO assists both in the application process and after the project has been granted.

FORNY 2020 is the Research Council’s own verification program. The projects must be at a more mature stage of development than is the case with Biotek2021 Optimalization, but still the early “high risk” phase.

So if you have a good idea, please contact BTO right away!

Emmet Mc Cormack
Randi Taxt, Vice-director BTO

ELECTION ANNOUNCMENT AND INVITATION TO PROMOTE CANDIDATE PROPOSALS

MEMBERS FOR THE INSTITUTE COUNCIL OF CLINICAL INSTITUTE 2 GROUP B

Members in Group B shall be elected to the Institute Council at Clinical Institute 2. The election is authorized by the University’s electoral rules. The Institute Council shall have members elected by and among:

  • Group A: Fulltime employed in teaching and research positions (including department managers)
  • Group B: Temporary employes in teaching and research
  • Group C: Technical and administrative staff
  • Group D: Students

Deadline for proposals of members (Group B) is set
Tuesday, April 10, 2018

Proposals must be sendt to the election board’s secretary, Irene Hjelmaas, departmental administration irene.hjelmaas@uib.noby kl. 15:00 Tuesday 10 April 2018.

The Institute Council shall have the following composition:

Group   Amount Function Period
Group B Temporary employes in teaching and research 1 + 3 deputy 1 Year – 01.08.2018 – 31.07.2019

The proposal must be in writing (on paper with physical signatures) and must be signed by at least three voters in the respective group. No one can sign on more than one suggestion.

The proposal must contain at least one and a maximum of four candidates. The suggested must be eligible. If the proposal is promoted to more than one candidate, it is encouraged to take gender balance into account.

In order to have the right to vote and to be eligible for Group B, one must have been employed before March 1 the election year in such post category as to be voted in and have a minimum of 50% position at the Clinical Institute 2, Faculty of Medicine.

information on incentives

The academic environment that want to apply for incentives will do this to the faculty on the attached application form. The faculty transmits applications collected to UiB. We request that applications from program committees and department will be sent to the faculty by 3 April 2018.

Guidelines Click HERE (only in norwegian)
Application form click HERE (only in norwegian)

 

 

Holidayinformation 2018

It’s time to start planning your leftover holidays.
The Faculty of Medicine has set the following deadlines for application for holidays for 2018:

Holiday Deadline for request Fixed holiday
Winter Holiday 01.02.2018 15.02.2018
Easter Holiday 01.03.2018 15.03.2018
Summer holiday (at least 3 weeks between (15.05-15.09) 01.04.2018 15.04.2018
Autumn Holiday 018 01.09.2018
Any leftover Holidays 01.10.2018 15.10.2018

Application for leftover holidays should be sent in PAGA no later than 01.10.2018.

Information about holidays and how to register holidays can be found here:
http://pagaweb.b.uib.no/english/5-vacation/

If you have any questions regarding Holidays and registering please contact Personnel Consultant:

Elin Myhrvold – Email: Elin.Myhrvold@uib.no Phone: 55972954

INSULIN GOES VIRAL

Invited talk by Prof. C. Ronald Kahn, Harvard Medical School.

One of the world’s—if not the world’s—leader in insulin signaling.

Date: Wednesday April 18th

Time: 09:00

Place: Auditorium @ Armauer Hansens hus, Haukeland University Hospital

Professor C. Ronald Kahn from Joslin Diabetes Center, Harvard Medical School is a world recognized expert in diabetes and obesity research, as well as a preeminent investigator in the area of insulin signal transduction and mechanisms of altered signaling in diabetes and metabolic disease.

Prof. Kahn has received more than 70 awards and honors, including the highest honors of the American Diabetes Association, U.S. and British Endocrine Societies, Juvenile Diabetes Research Foundation, European Association for the Study of Diabetes and the American Association of Clinical Endocrinologists, and election to the National Academy of Science and Institute of Medicine. He has authored more than 600 original publications and 200 reviews and chapters.

A recent study from Prof. Kahn has identified viruses that can produce insulin-like hormones that are active on human cells.  This novel discovery brings new possibilities for revealing biological mechanisms that may cause diabetes, as well as autoimmune disease, metabolic conditions or cancer.

Viruses known to infect fish and amphibians, could possibly expose humans to viral insulins. Prof. Kahn and his colleagues at Joslin have found that various viruses can produce peptides that are similar in whole or in part to 16 human hormones and regulatory proteins. Four viruses interestingly have insulin-like sequences, and show ability to bind to and stimulate human insulin receptors and receptors for a closely related hormone called IGF-1 (insulin-like growth factor 1). The viral peptides could this way potentially stimulate all signaling pathways inside the cells that are stimulated by human insulin and IGF-1, including glucose uptake and cellular growth.

NORPART – Norwegian Partnership Programme for Global Academic Cooperation

SIU has launched a new announcement through NORPART for the period 2019-223. The program supports academic partnerships and student mobility with an emphasis on Master and PhD level between higher education institutions in Norway and selected developing countries. The deadline is 31 May 2018 at 15:00.

PS: Please click here to find the letter regarding internal UiB guidelines for all applicants to NORPART 2018.

New Names


K2 presents Kadri Madissoo.
She was newly appointed 12.02.18 as a Senior Engineer and works at the research laboratory at KK.
She belongs to the research group G17 Gynecological Oncology, also known as Bergen Gynecological Cancer research group. She will also work with the research bio bank at the Women’s Clinic and is a safety representative.
If you wish to contact her or say hi, she can be contacted by mail Kadri.Madissoo@uib.no or she can be reached by phone at 55976336